Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense. Objective for Industry Day is to identify Industry partners and capabilities to help the JPEO ensure the Reactivating Nerve Agent Treatment System (RNATS) and Consolidated Nerve Agent Treatment System (CNATS) development efforts align with current, enduring, and emerging threats across agencies and services. Attendees Invited (RSVP), Mr. Ian Watson, SES Under Secretary of Defense for Acquisition and Biological, radiological Defense, Mr. Darryl Colvin, SES, Joint Program Executive Officer, Chemical, Biological, Radiological, Nuclear Defense. Ms. Nicole Kilgore, SES, Deputy Joint Program Executive Officer, Chemical, Biological, Radiological, Nuclear Defense, Dr. Robert Kristovich, SES, Director, Defense Threat Reduction Agency Chemical and Biological Technologies and Joint Science and Technology Office and Dr. Alison, Myska, Defense Threat Reduction Agency Chemical and Biological Technologies and Joint Science and Technology Guest speaker for Reactivativator and Multi-Drug Autoinjector Industry Day November 1, 2023 MITRE Virginia.